GlassScriptPhysician profile
Rene Alcides Exposito
NPI 1669012431
$1,371.40
in general payments reported to CMS, 2019-2025
13 companies · $39.06 in 2025
The $39.06 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $818 · 2022: $464 · 2023: $50.11 · 2025: $39.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $511.65 | 2021-2022 | |
| Theratechnologies INC. | $179.67 | 2021-2022 | |
| Janssen Biotech, INC. | $175.68 | 2021-2022 | |
| Janssen Products, LP | $169.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $68.18 | 2021 | |
| Gilead Sciences, INC. | $49.54 | 2021-2022 | |
| Emd Serono, INC. | $45.45 | 2021 | |
| Glaxosmithkline, LLC. | $41.52 | 2022-2025 | Shingrix |
| Hologic Sales and Service, LLC | $40.73 | 2023-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Bayer Healthcare Pharmaceuticals INC. | $26.41 | 2023 | |
| Novo Nordisk INC | $23.12 | 2022 | |
| Abbvie INC. | $22.44 | 2022 | |
| Amarin Pharma, INC. | $17.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Exposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.